Chronic myeloid leukemia is a proliferative disorder characterized by the dysregulated production and uncontrolled proliferation of mature and maturing granulocytes. It is characterized by the chromosomal translocation t(9;22)(q34.1;q11.2), which results in the formation of the Philadel­phia (Ph) chromosome and the BCR-ABL1 fusion gene.

Diagnostic Criteria (WHO 2016)

  • Peripheral and/or bone marrow blast less than 10%
  • Demonstration of the Philadelphia chromosome or the underlying t(9;22) translocation by conventional cytogenetic techniques 
Toggle Toolbar

Toolbar

Adjustments

Brightness
Contrast
Saturation
Zoom In
Zoom In
Toggle Full Screen
0 x

Blood Film Features:

  • Leucocytosis involving various stages of granulocytic maturation
  • Peaks in myelocytes & neutrophia
  • Blast less then 10% (Usually less than 2%)
  • Platelets may be normal or increased
  • Eosinophilia and Basophilia
  • No significant dysplasia
  • Cytochemistry:  neutrophil alkaline phosphate score low
Toggle Toolbar

Toolbar

Adjustments

Brightness
Contrast
Saturation
Zoom In
Zoom In
Toggle Full Screen
0 x

Bone Marrow Features:

  • Hypercellular bone marrow
  • Myeloid:Erythroid (M:E) ratio increased
  • Granulocytic hyperplasia involving various stages of maturation
  • Blast less than 10% (Usually less than 5%)
  • Small megakaryocytes with hypolobulated nuclei

Other features to look for:

  • Pseudo-Gaucher cells
  • Sea blue histiocytes

Other Resources